References
- Derkay CS. Task force on recurrent respiratory papillomas: a pre-liminary report. Arch Otolaryngol Head Neck Surg 1995;121:1386–91.
- Armstrong LR, Derkay CS, Reeves WC. Initial results from the national registry for juvenile-onset recurrent respiratory papillo-matosis. RRP Task Force. Arch Otolaryngol Head Neck Surg 1999;125:743–8.
- Silverberg MJ, Thorsen P, Lindeberg H, Ahdieh-Grant L, Shah KY Clinical course of recurrent respiratory papillomatosis in Danish children. Arch Otolaryngol Head Neck Surg 2004;130:711–6.
- Strong MS, Vaughan CW, Healy GB. Recurrent respiratory papillomatosis. In: Healy M. (ed) Laryngo-tracheal problems in the pediatric patient. Springfield: Thomas, 1979;88–98.
- Armstrong LR, Preston EJ, Reichert M, Phillips DL, Nisenbaum R, Todd NW et al. Incidence and prevalence of recurrent respira-tory papillomatosis among children in Atlanta and Seattle. Clin Infect Dis 2000;31:107–9.
- Handsfield HH, Waldo AB, Brown ZA, Corey L, Drucker JL, Ebel CW et al. Neonatal herpes should be a reportable disease. Sex Transm Dis 2005;32:521–5.
- Hajek E. Contribution to the etiology of laryngeal papilloma in children. J Laryngol Otol 1956;70:166.
- Cook TA, Cohn AM, Brunschwig JP et al. Laryngeal papilloma: etiologic and therapeutic considerations. Ann Otol Rhinol Laryngol 1973;82:649.
- Quick CA, Watts SL, Krzyzek RA et al. Relationship between condylomata and laryngeal papillomata. Ann Otol Rhinol Laryngol 1980;89:467.
- Silverberg MJ, Thorsen P, Lindeberg H, Grant LA, Shah KY Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol 2003;101:645–52.
- Wiatrak BJ, Wiatrak DW, Broker TR, Lewis L. Recurrent respira-tory papillomatosis: a longitudinal study comparing severity asso-ciated with human papilloma viral types 6 and II and other risk factors in a large pediatric population. Laryngoscope 2004;114(Suppl 104):1–23.
- Reidy PM, Dedo HH, Rabah R, Field JB, Mathog RH, Gregoire L et al. Integration of human papillomavirus type II in recurrent respiratory papilloma-associated cancer. Laryngoscope 2004;114:1906–9.
- Steinberg BM, Topp WC, Schneider PS, Abramson AL. Laryngeal papillomavirus infection during clinical remission. N Engl J Med 1983;308:1261–4.
- Smith EA, Pignatari SSN, Gray SD, Haugen TH, Turek LP. Human papillomavirus infection in papillomas and nondiseased respiratory sites of patients with recurrent respiratory papillo-matosis using the polymerase chain reaction. Arch Otolaryngol Head Neck Surg 1993;119:554–7.
- Abramson AL, Nouni M, Mullooly V, Fisch G, Steinberg BM. Latent human papillomavirus infection is comparable in the lar-ynx and trachea. J Med Virol 2004;72:473–7.
- Shah KY, Kashima H, Polk BF, Abbey H, Shah F, Abramson A. Rarity of cesarean delivery in cases of juvenile-onset respiratory papillomatosis. Obstet Gynecol 1986;68:795–9.
- Kashima K, Shah F, Lyles A, Glackin R, Muhammad N, Turner L et al A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope 1992;102:9–13.
- Shah KY, Stern WF, Shah FK, Kashima HK. Risk factors for juvenile-onset recurrent respiratory papillomatosis. Pediatr Infect Dis J 1998;17:372–6.
- Tang CK, Shermeta DW, Wood C. Congenital condylomata acuminata. Am J Obstet Gynecol 1978;131:912.
- Kosko JR, Derkay CS. Role of cesarean section in prevention of recurrent respiratory papillomatosis - is there one? Int J Pediatr Otorhinolaryngol 1996;35:31–38.
- Bauman NM, Smith RJ. Recurrent respiratory papillomatosis. Pediatr Clin North Am 1996;43:1385–401.
- American College of Obstetrics and Gynecology. Guidelines for Perinatal Care, 3rd edn. Washington, DC: American College of Obstetrics and Gynecology, 1992.
- Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002;347:1645–51.
- Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR et al. Prophylactic quadrivalent human papillomavirus (types 6,11,16, and 18) Li virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271–8.
- Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A et al. Efficacy of a bivalent Li virus-like particle vac-cine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004;364:1757–65.
- Anonymous. Condyloma acuminatum: United States. MMWR 1983;32:306.
- Dunne EF, Meadows KS, Sternberg MR, Karem KL, Stone KM, Unger ER et al. HPV-I1 seroprevalence in persons age 6–59 years in the United States, 1991–1994. Presented at the 22nd Int Papillomavirus Conference, Vancouver. 2005.
- Stone KM, Karem KL, Sternberg MR, McQuillan GM, Poon AD, Unger ER et al. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis 2002;186:1396–402.
- Laukkanen P, Koskela P, Pukkala E, Dillner J, Laara E, Knekt P et al. Time trends in incidence and prevalence of human papillo-mavirus type 6,11 and 16 infections in Finland. J Gen Virol 2003;84:2105–9.
- Breitburd F, Kimbauer R, Hubbert NL, Nonnenmacher B, Trin-Dinh-Desmarquet C, Orth G et al. Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can pro-tect against experimental CRPV infection. J Virol 1995;69:3959–63.
- Christensen ND, Reed CA, Cladel NM, Han R, Kreider JW. Immunization with virus-like particles induces long-term protec-tion of rabbits against challenge with cottontail rabbit papillo-mavirus. J Virol 1996;70:960–5.
- Brown ZA, Benedetti J, Ashley RL, Burchett S, Selke S, Berry S et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991;324:1247–52.
- Whitley RJ. Herpes simplex viruses. In: Knipe DM, Howley PM. (eds) Fields' Virology. Philadelphia, PA: Lippincott Williams & Wilkins, 2001;2461–509.
- Huang K, Lin S. Nationwide vaccination: a success story in Taiwan. Vaccine 2000;18 ( Suppl I):535–8.